Search
Returning search results with filters:
Remove filter for
Category: Health product
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 379 items.
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2022-08-15
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.
Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
AlertPublic advisory | 2022-08-09
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.
Atorvastatin is a…
AlertPublic advisory | 2022-08-06
Health Canada is warning consumers about counterfeit BTNX Rapid Response COVID-19 antigen rapid test kits (25-pack boxes) found in Ontario. The counterfeit devices were sold online by a distributor named Healthful Plus, without the required licence to…
AlertPublic advisory | 2022-08-05
Health Canada seized numerous unauthorized health products from Productos Latinos El Aguila located at 42 Erie St S, Leamington, Ontario. The seized products include seven that are labelled to contain prescription drugs and may pose serious health risks…
AlertPublic advisory | 2022-08-05
On July 27, 2022, Bavarian Nordic submitted data to Health Canada characterizing shelf life for alternative storage conditions for IMVAMUNE. The IMVAMUNE Vaccine Product Monograph indicates: “Store frozen at -20°C ± 5°C or -50°C ± 10°C or -80°C ± 10°C.…
AlertHealth professional risk communication | 2022-07-29
UPDATE (July 28, 2022): Update: Apotex recalls additional Apo-Acyclovir tablets due to a nitrosamine impurity
Apotex Inc. is recalling four additional lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a…
AlertPublic advisory | 2022-07-28
UPDATE (2022-07-27): Update on Philips Respironics recall of several models of CPAP and BiLevel PAP machines and mechanical ventilators
Health Canada is providing an update on the progress of Philips Respironics’ (Philips) recall of several models of…
AlertPublic advisory | 2022-07-27
Health Canada is advising that all lots of Equate (lemon flavour), Life Brand (lemon and cherry flavours) and Personnelle (lemon flavour) Magnesium citrate oral solution saline laxative (NPN 80015316) are being recalled by the importer, Shandex Sales…
AlertPublic advisory | 2022-07-24
As part of Operation Pangea XV — an international effort to disrupt the online sale of counterfeit and other illegal health products around the world—Health Canada is reminding consumers to be careful when buying health products over the Internet. Health…
AlertPublic advisory | 2022-07-20
Certain lots of hand sanitizers do not meet Health Canada requirements. Issues include:
containing (or possibly containing) ingredients that are not permitted by Health Canada;
containing undeclared impurities at elevated levels;
improper…
AlertPublic advisory | 2022-07-11
UPDATE: June 29, 2022
There continues to be a national shortage of specialized infant formulas for infants with food allergies and certain medical conditions. This includes extensively hydrolyzed formulas and amino acid-based formulas. There is no…
AlertPublic advisory | 2022-06-29
UPDATE (June 15, 2022):
Health Canada is warning consumers about additional unauthorized products seized from three herbal medicine stores in Calgary, Alberta, after testing found they contain drugs that are not listed on the product label, which may…
AlertPublic advisory | 2022-06-16
A new presentation of SPIKEVAX (elasomeran) with a concentration of 0.10 mg/mL in a 2.5 mL multidose vial was authorized on June 01, 2022. In order to provide rapid access to the new presentation of SPIKEVAX (0.10 mg/mL, 2.5 mL multidose vial), Moderna…
AlertHealth professional risk communication | 2022-06-06
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-06-03